Stock PD2 PATTERSON COMPANIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Patterson Companies, Inc. Berne S.E.

Equities

PD2

US7033951036

Delayed Berne S.E.
Other stock markets
 		5-day change 1st Jan Change
- CHF -.--% Intraday chart for Patterson Companies, Inc. -.--% -.--%
20/06 Morgan Stanley Adjusts Price Target on Patterson Companies to $28 From $30, Maintains Equalweight Rating MT
20/06 JPMorgan Adjusts Price Target on Patterson Companies to $29 From $30, Maintains Neutral Rating MT

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

  • The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.38 for the 2025 fiscal year.
  • Given the positive cash flows generated by its business, the company's valuation level is an asset.
  • The company is one of the best yield companies with high dividend expectations.
  • Considering the small differences between the analysts' various estimates, the group's business visibility is good.
  • Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
  • Historically, the company has been releasing figures that are above expectations.

Weaknesses

  • With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • The company does not generate enough profits, which is an alarming weak point.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
PATTERSON COMPANIES, INC. Stock Patterson Companies, Inc.
-.--% 212.2Cr -
ABBOTT LABORATORIES Stock Abbott Laboratories
-4.16% 18TCr
C+
MEDTRONIC PLC Stock Medtronic plc
-2.39% 10TCr
C
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-4.08% 6.76TCr
A
CENCORA, INC. Stock Cencora, Inc.
+16.04% 4.69TCr
B-
DEXCOM, INC. Stock DexCom, Inc.
-11.10% 4.39TCr
B-
HOYA CORPORATION Stock Hoya Corporation
+8.28% 4.12TCr
B+
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+17.63% 3.05TCr
B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-8.10% 2.36TCr
A-
TERUMO CORPORATION Stock Terumo Corporation
+13.59% 2.42TCr
A-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. PDCO Stock
  4. PD2 Stock
  5. Ratings Patterson Companies, Inc.